Approximately 40% of the human breast cancers show a positive TGF-β gene response signature, that is context dependent and appears more in ER-tumors (as opposed to ER+ tumors) and in lung metastasis (as opposed to bone metastasis) [8, 60]. This evidence concerns the gene TGFB1 and breast cancer.